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1 
2 
3 ABSTRACT 
4 
5 
6 Mevalonate kinase (MVK) catalyses the phosphorylation of mevalonate.  Deficiency of MVK is 
7 
8 associated with two rare periodic fever syndromes, mevalonic aciduria (MA), a severe form and 
9 
10 hyper-Immunoglobulin-D syndrome (HIDS), a milder form. An in silico approach was used to analyse 
11 
12 
the physicochemical and structural effects of 47 disease-associated variants of MVK. A further 20 
13 
14 
15 variants, which are present in human genome databases, were also analysed. Variants associated 
16 
17 with MA are clustered into a “hotspot” consisting of residues 8-35 and 234-338 and tended to result 
18 
19 in a prediction of severely reduced protein stability.  Four of the uncharacterised variants, p.H24P, 
20 
21 p.G198R, p. R253W and p.G335S were likely to be associated with MA. This method could be used as 
22 
23 the basis for initial predictions of severity when new MVK variants are discovered. 
24 
25 
26 
27 
28 
29 Keywords:   periodic fever syndrome; mevalonic aciduria; hyper-Immunoglobulin-D syndrome; HIDS; 
30 
31 protein stability; disease prediction 
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the human MVK enzyme is very similar to the rat one (rmsd 0.81 Å) and the mechanism of reaction is 
expected to be identical with Asp-204 acting as a base in the active site (Fu et al. 2008). 
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1 
2 
3 INTRODUCTION 
4 
5 
6 Mevalonate kinase (MVK) deficiency is associated with a wide range of systemic diseases ranging 
7 
8 from the most severe form, mevalonic aciduria (MA; OMIM#610377) to a milder form, hyper- 
9 
10 immunoglobulin D syndrome (HIDS; OMIM#60920) (Drenth et al. 1999, Haas & Hoffmann 2006, 
11 
12 
Houten et al. 2000b). These rare autosomal recessive disorders are caused by a mutation in the MVK 
13 
14 
15 gene, which is found on the long arm of chromosome 12 (12q24) (Haas & Hoffmann 2006, Houten et 
16 
17 al. 2000b, Houten et al. 2000a).  Mevalonate kinase (EC 2.7.1.36) is an essential enzyme in the 
18 
19 cholesterol pathway (Buhaescu & Izzedine 2007). It is a dimeric protein that catalyses the ATP- 
20 
21 dependent phosphorylation of mevalonate to 5-phosphomevalonate (Potter & Miziorko 1997). This 
22 
23 step follows the one catalysed by the highly regulated enzyme and statin target, 3-hydroxy-3- 
24 
25 
methylglutaryl-CoA  (HMG-CoA) reductase (EC 1.1.1.34). Although there is no effective treatment for 
26 
27 
28 
MVK deficiency, preliminary evidence has shown that Simvastatin, an HMG-CoA reductase inhibitor, 
29 
30 may be useful in treating inflammatory attacks in HIDS (Simon et al. 2004). 
31 
32 
33 MVK is part of the GHMP family of kinases (Bork et al. 1993, Timson 2007). Each subunit has two 
34 
35 domains with the active site located in a cleft at the domain interface (Yang et al. 2002, Fu et al. 
36 
37 2002, Sgraja et al. 2007, Fu et al. 2008). The enzyme is dimeric. Thus, mutations causing amino acid 
38 
39 changes at the dimer interface may disrupt dimer formation leading to an inactive or unstable 
40 
41 protein (Fu et al. 2002).  The crystal structure of rat mevalonate kinase in complex with MgATP 
42 
43 
revealed that an Mg2+ ion is co-ordinated by both β- and γ-phosphates of ATP and side chains of Glu- 
45 
46 193 and Ser-146 (Fu et al. 2002). Asp204 was found to make a salt bridge with Lys-13, which 
47 
48 interacts with the γ-phosphate (Fu et al. 2002). Lys-13 affects the pKa of the C5 hydroxyl of 
49 
50 mevalonate, while Asp-204 abstracts the proton from this hydroxyl. The resulting penta-coordinated 
51 
52 γ-phosphoryl group may be stabilized by Mg2+, Lys-13, and Glu-193 (Fu et al. 2002).  The structure of 
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deficiency is particularly common in northern Europe (especially the The Netherlands and France) 
but cases have been reported worldwide (Prietsch et al. 2003). Approximately 80 mutations have 
been reported to cause mevalonate kinase deficiency (Haas & Hoffmann 2006). 
 
 
 
 
1 
2 
3 MA and HIDS are rare autosomal recessive disorders characterised by recurrent periodic fevers and 
4 
5 generalised inflammation (Haas & Hoffmann 2006, Frenkel et al. 2000). Typical symptoms of the 
6 
7 severe form, MA, can include psychomotor retardation, ataxia, failure to thrive, dysmorphic features 
8 
9 
with recurrent episodes of fevers, lymphadenopathy and rashes (Frenkel et al. 2000, van der Burgh 
10 
11 
12 et al. 2013). These symptoms typically present in infancy and patients usually die in childhood 
13 
14 (Frenkel et al. 2000). Suffers of MA can be confirmed based on their biochemical, clinical and genetic 
15 
16 data (Drenth et al. 1999). The residual activity of MVK in MA sufferers is below 0.5%, leading to a 
17 
18 characteristic build-up of mevalonic acid (Prietsch et al. 2003). 
19 
20 
21 HIDS is a milder phenotype of MVK deficiency with more documented cases (Haas & Hoffmann 
22 
23 2006, Frenkel et al. 2000, van der Burgh et al. 2013, Grose 2005). Symptoms usually present in the 
24 
25 
first year of life and include recurrent lifelong episodes of fever, rashes, abdominal pain and 
26 
27 
28 
lymphadenopathy (Haas & Hoffmann 2006, Frenkel et al. 2000, McDermott & Frenkel 2001, Haas et 
29 
30 al. 2001, Hoffman et al. 2001). A high level of IgD and IgA accompanies these symptoms and is often 
31 
32 used as a diagnostic confirmation of HIDS (Drenth et al. 1999, Houten et al. 2000b, Buhaescu & 
33 
34 Izzedine 2007). Moreover the residual activity of MVK in HIDS is around 1-20% (Houten et al. 2000b). 
35 
36 HIDS can be distinguished from MA by the lack of abnormal levels of mevalonic acid present as well 
37 
38 
as the lack of neurological manifestations which feature in MA (Hoffman et al. 2001). Furthermore 
39 
40 
41 
unlike individuals with MA, people suffering with HIDS do not experience any symptoms between 
42 
43 fever episodes and typically have a normal life expectancy (Haas & Hoffmann 2006). 
44 
45 
46 The most frequent mutation associated with HIDS is c.1129G>A (rs28934897) resulting in an amino 
47 
48 acid change from valine to isoleucine at position 377 (p.V377I) (Cuisset et al. 2001). This is found in 
49 
50 approximately 80% of HIDS suffers and has never been reported in MA (Cuisset et al. 2001). MVK 
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MATERIALS AND METHODS 
 
 
 
1 
2 
3 Overlapping phenotypes of MA and HIDS have been observed in an intermediate form, although few 
4 
5 cases have been documented (Hoffman et al. 2001).  However it is important to note that the 
6 
7 relationship between mutation and reported phenotype may not always be straightforward. 
8 
9 
Phenotypes are classified based on individual clinical observation and can be influenced by 
10 
11 
12 environmental factors; for example, the symptoms of MVK deficiency appear to be amplified by 
13 
14 increased temperature (Houten et al. 2002, Tricarico et al. 2013). 
15 
16 
17 It is not known precisely how each disease-associated mutation alters the enzyme structure or how 
18 
19 this contributes to the different levels of severity or pathology. It is assumed that the residual 
20 
21 activity of MVK determines whether or not a patient has MA or HIDS, therefore a mutation 
22 
23 associated with the severe form must disrupt the enzyme’s structure and function significantly to 
24 
25 
decrease its activity below 0.5%. At the biochemical level this is likely to result from effects on 
26 
27 
28 
protein folding and stability. A bioinformatics approach was taken to understand the functional and 
29 
30 structural contribution of molecular alterations in MVK and how these correlate to the associated 
31 
32 severity.  This was then applied to variants of MVK whose disease association is currently unknown. 
33 
34 The approaches can be broadly arranged into three approaches: sequence and evolutionary 
35 
36 conservation based methods, protein sequence and structure-based methods, and supervised 
37 
38 
learning methods.  Similar approaches have been successful in the investigation of type I 
39 
40 
41 
galactosemia (galactose 1-phosphate uridylyltransferase  deficiency), type III galactosemia (UDP- 
42 
43 galactose 4’-epimerase deficiency), hyperargininemia  (arginase 1 deficiency) and apparent 
44 
45 mineralocorticoid  excess (11β-hydroxysteroid  dehydrogenase type 2 deficiency) to provide the basis 
46 
47 for predicting the severity of newly discovered mutations (Carvalho et al. 2012, Manning et al. 2010, 
48 
49 Facchiano & Marabotti 2010, d'Acierno et al. 2009, d'Acierno et al. 2014, McCorvie & Timson 2013). 
50 
51 
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buried atoms from the variant compared to the wild type (Fraczkiewicz & Braun 1998). 
 
 
 
 
1 
2 
3 Datasets, sequence information and data analysis 
4 
5 
6 Literature searches were used to identify disease-associated variants. Where available, the clinical 
7 
8 symptoms, observed residual activity of the MVK variant, any biochemical analysis (including any 
9 
10 experimental conditions), environmental factors and the genetic background were noted. 
11 
12 
Characterised variants and uncharacterised missense mutations from exome sequencing were 
13 
14 
15 identified from the databases: NCBI dbSNP (http://www. ncbi.nlm.nih.gov/SNP/), UniProt 
16 
17 (http://www.uniprot.  org), and Infevers (http://fmf.igh.cnrs.fr/ISSAID/ infevers/). Excel (Microsoft) 
18 
19 and GraphPad Prism 5.0 (GraphPad Software) were used to record scores, perform statistical 
20 
21 analysis and obtain graphical representations of the results. 
22 
23 
24 
25 
26 
27 Secondary and tertiary structural investigations 
28 
29 
30 Structural studies were based on the crystal structure of human MVK (PDB:  2R3V) (Fu et al. 2008). 
31 
32 Structures were visualised using PyMol (http://www.pymol.com) and were computationally solvated 
33 
34 and energy minimized using YASARA (http://www.yasara.org) (Krieger et al. 2009). Sequence 
35 
36 
variations were introduced in silico using the Mutate function in PyMol and these variant forms of 
37 
38 
39 the protein were minimised using YASARA. Thus, all structural comparisons were made using 
40 
41 minimised structures. Each variant’s structure was further analysed using LS-SNP/PDB (http://ls- 
42 
43 snp.icm.jhu.edu/ls-snp-pdb/main). This tool provided solvent accessibility scores, variant’s position 
44 
45 at domain interface, location in the 3D structure, if it is exposed or buried, the secondary structure 
46 
47 where the variant is found and a 3D representation of the variant in the structure.  The GETAREA 
48 
49 
server (http://curie.utmb.edu/ getarea.html) was used to determine the change in surface and 
52 
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60 
solvent accessibility were: PoPMuSiC 2.1 (Dehouck et al. 2011); CUPSAT RSA ((http://cupsat.tu- 
bs.de) (Parthiban et al. 2007); SDM score (Worth et al. 2011, Worth et al. 2007); BeAtMuSiC 
(Dehouck et al. 2013). 
 
47 
 
 
1 
2 
3 Prediction of the physicochemical effect of each missense mutation on MVK structure, stability and 
4 
5 function 
6 
7 
8 Bioinformatics tools were used to investigate a range of physicochemical effects of each variant on 
9 
10 MVK’s structure and function. The following tools were used to estimate the change in protein 
11 
12 
stability: I-Mutant 3.0 Binary and Ternary classification 
13 
14 
15 (http://gpcr2.biocomp.unibo.it/cgi/predictors/I-Mutant3.0/I-Mutant3.0.cgi) (Capriotti et al. 2005, 
16 
17 Capriotti et al. 2006); mCSM (http://bleoberis.bioc.cam.ac.uk/mcsm/) (Pires et al. 2014); SDM score 
18 
19 (http://mordred.bioc.cam.ac.uk/~sdm/sdm.php) (Worth et al. 2011, Worth et al. 2007); Mupro 
20 
21 (http://mupro.proteomics.ics.uci.edu/) (Cheng et al. 2006); iStable score 
22 
23 (http://predictor.nchu.edu.tw/iStable/) (Chen et al. 2013); PredictSNP 1.0 
24 
25 
(http://loschmidt.chemi.muni.cz/predictsnp/) (Bendl et al. 2014); Meta-SNP 
26 
27 
28 
(http://snps.biofold.org/meta-snp/) (Capriotti et al. 2013); KD4V score 
29 
30 (http://decrypthon.igbmc.fr/kd4v) (Luu et al. 2012). 
31 
32 
33 The tools used to estimate the change in free energy resulting from the point mutations (all 
34 
35 calculated at pH 7.5, 30 °C) were: I-Mutant 3.0 DDG, SVM3 and SVM2 values  (Capriotti et al. 2006); 
36 
37 Fold-X DDG value (http://foldx.crg.es)  (Schymkowitz et al. 2005); PoPMuSiC 2.1 
38 
39 (http://dezyme.com/)  (Dehouck et al. 2011); CUPSAT DDG ((http://cupsat.tu-bs.de) (Parthiban et al. 
40 
41 2006, Parthiban et al. 2007); iStable DDG (Chen et al. 2013); GETAREA energy change 
42 
43 
44 
(http://curie.utmb.edu/getarea.html) (Fraczkiewicz & Braun 1998). 
45 
46 
The tools used to predict change in binding affinity were: mCSM Protein-Protein affinity prediction 
 
48 
49 (Pires et al. 2014); BeAtMuSiC binding affinity prediction and score 
50 
51 (http://babylone.ulb.ac.be/beatmusic) (Dehouck et al. 2013). The tools used predict the change in 
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each amino acid alteration using the SIFT server (http://sift.jcvi.org/)  (Kumar et al. 2009) and the 
PROVEAN server (http://provean.jcvi.org/index.php) (Choi et al. 2012), both of which are based on 
updated versions of Ensembl gene annotation (GRCh37 Ensembl 66) and NCBI dbSNP database 
(Build 137). 
 
 
34 
47 
 
 
1 
2 
3 In addition, further physicochemical analysis was carried out using SNP effect 4.0 server 
4 
5 (http://snpeffect.switchlab.org) (De Baets et al. 2012) which uses four programs to predict the 
6 
7 biochemical effects of missense mutations; TANGO (http://tango.crg.es/)  (Fernandez-Escamilla  et al. 
8 
9 
2004) which predicts the tendency to aggregate; Fold-X (Schymkowitz et al. 2005) which predicts 
10 
11 
12 changes in stability, WALTZ (http://www.switchlab.org/bioinformatics/waltz ) (Maurer-Stroh et al. 
13 
14 2010) which predicts the tendency to form amyloids and LIMBO 
15 
16 (http://www.switchlab.org/bioinformatics/limbo) (Van Durme et al. 2009) which predicts the ability 
17 
18 to bind chaperones. A estimation of the change in hydrogen bond satisfaction was also carried out 
19 
20 using SDM (Worth et al. 2011, Worth et al. 2007). The KD4V server (Luu et al. 2012) provided 
21 
22 
additional scores in the change in size, charge polarity, modifications and hydrophobicity. Change in 
23 
24 
25 hydrophobicity scores were calculated using data from (Black & Mould 1991). 
26 
27 
28 
29 
30 
31 
Multiple sequence alignment and evolutionary conservation based methods 
32 
33 
Multiple sequence alignment was carried out using Clustal Omega 
 
35 
36 (http://www.ebi.ac.uk/Tools/msa/clustalo/) (Sievers et al. 2011) from sequences gathered from 
37 
38 UniProt database (http://www.uniprot.org).  Only those classified as MVK and with “reviewed” 
39 
40 status were used. A total of 19 sequences were obtained, which included one from yeast, four from 
41 
42 vertebrates, one from slime mould, one from plants, one from Archaea and eleven from eubacteria. 
43 
44 The resulting alignment (Supplementary Figure S1) was used with the Scorecons server 
45 
46 
(https://www.ebi.ac.uk/thornton-srv/databases/cgi-bin/valdar/scorecons_server.pl) based on the 
 
48 
49 Valdar01 score (Valdar 2002).  The alignment was also used to calculate the degree of tolerance of 
52 
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56 
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2013); FI mutation assessor (Reva et al. 2011); BeAtMuSiC (Dehouck et al. 2013).  
34 
47 
 
 
1 
2 
3 Additional investigations of the tolerance to change at positions which are altered in the disease- 
4 
5 associated variants was carried out using the tools: LS-SNP/PDB (http://ls-snp.icm.jhu.edu/ls-snp- 
6 
7 pdb/) (Ryan et al. 2009); SNPs&GO (http://snps.biofold.org/snps-and-go/pages/help.html) 
8 
9 
(Calabrese et al. 2009); PhD-SNP (http://snps.biofold.org/phd-snp/phd-snp.html) (Capriotti et al. 
10 
11 
12 2006); PANTHER (http://www.pantherdb.org/tools/csnpScoreForm.jsp) (Brunham et al. 2005); 
13 
14 GenMAPP (http://www.genmapp.org) (Salomonis et al. 2007); PolyPhen 2 
15 
16 (http://genetics.bwh.harvard.edu/pph2/) (Adzhubei et al. 2010, Adzhubei et al. 2013); nsSNP 
17 
18 Analyzer (http://snpanalyzer.uthsc.edu) (Bao et al. 2005); FI mutation assessor 
19 
20 (http://mutationassessor.org/v1) (Reva et al. 2011); KD4V (Luu et al. 2012); YALE MU2A 
21 
22 
(http://krauthammerlab.med.yale.edu/mu2a) (Garla et al. 2011). 
23 
24 
25 
26 
27 
28 Supervised learning methods for combined overall predictions of each variant severity 
29 
30 
31 Supervised learning methods that include a variety of bioinformatics tools to compare variants and 
32 
33 
provide an overall prediction on the effect of the variant on the protein’s structure, function and 
 
35 
36 pathology were used. Programs that provided this overall score, predicting if the mutation was 
37 
38 disease causing, damaging, destabilizing or deleterious were: I-Mutant 3.0 Prediction of Disease 
39 
40 (Capriotti et al. 2006); SIFT (Kumar et al. 2009); PROVEAN prediction (Choi et al. 2012); PolyPhen 2 
41 
42 prediction (Adzhubei et al. 2013); mCSM prediction (Pires et al. 2014); SNAP prediction 
43 
44 (https://www.rostlab.org/services /snap/) (Bromberg & Rost 2007); PANTHER (Brunham et al. 2005); 
45 
46 
PhD-SNP predictor (Capriotti et al. 2006); nsSNP Analyzer (Bao et al. 2005); Mupro prediction (Cheng 
 
48 
49 et al. 2006); PoPMuSiC 2.1 (Dehouck et al. 2011); CUPSAT (Parthiban et al. 2007); iStable (Chen et al. 
50 
51 2013);  PredictSNP (Bendl et al. 2014); MAPP (Salomonis et al. 2007); Meta-SNP (Capriotti et al. 
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Computational analysis tends to place the MVK variants into two groups 
All the results from the physicochemical analysis of the disease-associated and uncharacterised 
variants are given in Supplementary Table S1. There was a tendency to predict decreasing structural 
 
 
 
 
1 
2 
3 RESULTS AND DISCUSSION 
4 
5 
6 MVK alterations associated with MA tend to located in the central cleft, near the active site 
7 
8 
9 Literature and database searches identified forty-seven MVK mutations for which there was 
10 
11 sufficient biochemical and clinical information to be included in this study. Four of these were 
12 
13 associated with the intermediate severity MVK deficiency, twelve with the severe form (MA) and the 
14 
15 
remainder with the mild form (HIDS).  The location of the changes in the protein sequence showed 
16 
17 
18 
that there was a relationship between the position of the variant and associated severity, with 
19 
20 severe and intermediate mutations only occurring between amino acid positions 8-35 and 234-338 
21 
22 (Figure 1). These two sequences are located around the inside of the protein’s cleft close to the 
23 
24 active site and around the domain interface.  Four of the variations associated with the severe form 
25 
26 (p.L264F, p.L265P, p.I268H and p.N301T) occur in α-helices at the dimer interface.  To our 
27 
28 knowledge there is no published information on the effect of these (or other) mutations on the 
29 
30 
31 
ability of MVK to dimerise; nor is there any information on whether, or not, dimerization is required 
32 
33 for full activity of human MVK.  However, MVK from some bacteria is monomeric, suggesting that 
34 
35 the oligomeric state may have limited impact on activity (Hedl & Rodwell 2004, Voynova et al. 2004). 
36 
37 The alterations associated with HIDS were more widespread throughout the MVK structure (Figure 
38 
39 1). The position of the variants in the 3D structure from LS-SNP/PDB showed that the majority of 
40 
41 variants associated with severe and intermediate forms of the disease affected buried residues, 
42 
43 
44 
while the variants associated with HIDS affected a mixture of buried, intermediate and exposed
 
45 
46 residues. 
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unknown severity.  
34 
47 
 
 
1 
2 
3 stability with increasing severity of the disease-associated variants. The programs that gave this 
4 
5 trend with were: I-Mutant DDG, solvent accessibility, FOLD-X, mCSM stability, Mupro, PoPMuSiC 2.1, 
6 
7 BeAtMuSiC, CUPSAT (RSA), iStable DDG, GETAREA, SDM, BETAMUSIC, and KD4V. The change in 
8 
9 
hydrophobicity tended to increase with severity (data not shown). In the majority of cases, however, 
10 
11 
12 there was no statistical significance (p>0.05) when the three groups (mild, intermediate and severe) 
13 
14 were compared.  In general, alterations at more highly conserved residues were more likely to result 
15 
16 in severe forms of MVK deficiency. This result was supported by predictions from: POLYPHEN-2, 
17 
18 SAM, SCORECONS, PHD-SNP, SNP&GO, PANTHER, MAPP, FI-mutant and 4D4V WT residue 
19 
20 representation.  However, like the physiochemical scores, there was no significant difference 
21 
22 
between the scores when comparing the results from the three groups with the majority of the 
23 
24 
25 programs (data not shown). 
26 
27 
28 
29 
30 
31 
Supervised learning methods predict effects on MVK stability using a combination of methods 
32 
33 
Programs that used supervised learning methods for an overall prediction were used to predict each 
 
35 
36 variant’s effect on MVK’s stability. It should be noted that this approach is based on the assumption 
37 
38 that all the prediction tools are equally good. However, the percentage score provides an overall 
39 
40 consensus which has been found to be more accurate than only using one or two tools (Zhao et al, 
41 
42 2014). The results in Supplementary Table S2 are based on 28 prediction tools and show that, in 
43 
44 general, the percentage of tools predicting a reduction in MVK stability slightly increases with 
45 
46 
increasing severity. For each group the percentage predicting a decrease ranged from: 28.6-89.3 
 
48 
49 (mild), 53.6-89.3 (intermediate) and 64.3-92.9 (severe). Although there is an increasing trend, the 
50 
51 discrimination between groups was not sufficient to make meaningful predictions about variants of 
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1 
2 
3 The intermediate form was not well detected by these methods 
4 
5 
6 Across the three different prediction methods, the intermediate group was not well discriminated. 
7 
8 In general it showed results similar to, or greater than, the severe group (Supplementary Table S1). 
9 
10 This suggests that either these methods are not sufficiently discriminating or that the intermediate 
11 
12 
group would be better considered as part of the severe group.  Combining these two groups enabled 
13 
14 
15 discrimination between the combined intermediate/severe  group and the mild group on the basis of 
16 
17 the physicochemical scores (Figure 2). Therefore, in developing a predictive framework, these two 
18 
19 groups were considered together. 
20 
21 
22 
23 
24 
25 Towards a predictive framework:  four key postulates 
26 
27 
28 Based on the data (summarised in Supplementary Table S2), four postulates were made: 
29 
30 
31 1.    The decrease in enzyme activity is correlated with severity of disease.  In the majority of 
32 
33 cases, this decrease results from improper folding of the protein. 
34 
35 
36 2.    Changes to highly conserved residues are more likely to result in improper folding. 
37 
38 
39 3.    Intermediate mutations should be treated with the severe group due to their similarity to 
40 
41 this group. 
42 
43 
44 4.    For a severe or intermediate phenotype to occur, the mutation is likely to cause a change in 
45 
46 the “hotspot” region, identified from structural analysis, i.e. around residues 8-35 and 234- 
47 
48 338 in the protein sequence. 
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alleviation of the feverish episodes in HIDS.  
 
 
1 
2 
3 Prediction of the likely clinical severity associated with uncharacterised variants 
4 
5 
6 There are a number of variants which have been identified through genome and exome sequencing 
7 
8 projects, but have not yet been characterised in terms of their associated disease severity. Applying 
9 
10 the postulates above, four of these variants are predicted to be associated with the intermediate or 
11 
12 
severe form (MA).  These are p.H24P, p.G198R, p.R253W and p.G335S (Supplementary Table S3). 
13 
14 
15 Three of these uncharacterised variants were predicted to cause either the mild form (HIDS) or no 
16 
17 disease and the rest were predicted to be associated with HIDS (Supplementary Table S3). 
18 
19 Experimental testing will be necessary to confirm these predictions.  Molecular dynamics simulations 
20 
21 may be valuable in explaining why disease-associated variants affect protein stability and would also 
22 
23 be useful in investigating the properties of these uncharacterised variants.   It is further 
24 
25 
hypothesised that the MVK variants which are predicted to be associated with MA will have very low 
26 
27 
28 
activities and stabilities in vitro.  It is also expected that cells homozygous for the corresponding 
29 
30 mutations are likely to be deficient in the mevalonate pathway and will accumulate mevalonate. 
31 
32 
33 
34 
35 
36 Conclusions 
37 
38 
39 The analyses presented here suggest that point mutations in the MVK gene which result in changes 
40 
41 to the protein coding sequence subtly alter the structure and stability of MVK, thus affecting it 
42 
43 activity. These effects are greater when the change occurs in a well-conserved residue. Variants 
44 
45 associated with MA generally result in changes to the highly conserved “hotspot” region and also 
46 
47 result in greater changes to stability and other biophysical parameters.  In addition to providing a 
48 
49 
predictive framework, these results also suggest that pharmacological interventions to stabilise the 
50 
51 
52 MVK protein (“small molecule chaperone therapy”) may be possible in the treatment of MA and the 
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Supplementary Table S2: The percentage of predictions from 28 prediction tools (see Materials and 
Methods) for MVK variants predicting a decrease, increase or neutral change in stability.  Whether 
or not the residue occurs in the structural “hotspot” is also tabulated. 
 
 
 
 
1 
2 
3 Figure legends 
4 
5 
6 Figure 1:  Structure of human mevalonate kinase showing the location of changes resulting from 
7 
8 disease-associated mutations.  (a)  The dimeric structure of human MVK showing the N- and C- 
9 
10 termini and active site cleft of one of the subunits.    (b) The sequence of human MVK (GenBank: 
11 
12 
NP_001107657) showing residues which when altered are associated with mild (green), 
13 
14 
15 intermediate (magenta) and severe (red) forms of MVK deficiency.  (c) These residues mapped onto 
16 
17 the three dimensional structure of a single MVK subunit (left).  Each residue associated with disease 
18 
19 is shown as a space-filled model.  Those associated with the severe form (MA) are coloured red. 
20 
21 Magenta indicates residues which are altered in the intermediate form and green residues altered in 
22 
23 the mild form (HIDS).  The “hot-spot” which includes all the alterations associated with MA is 
24 
25 
coloured blue in the right hand figure.  Parts (a) and (c) were produced using PyMol and (PDB:  2R3V) 
26 
27 
28 (Fu et al. 2008). 
29 
30 
31 
Figure 2:  When combined, the intermediate and severe groups of variants show a statistically 
32 
33 significant difference from the mild variants in the mean physicochemical score (p=0.038). 
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39 Supporting  Information 
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42 Supplementary Figure S1:  A sequence alignment generated in Clustal Omega (see Materials and 
43 
44 Methods) of 19 verified MVK protein sequences.  This alignment was used in analysis of sequence 
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49 Supplementary Table S1:  The complete dataset from the various prediction tools used in this study. 
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Supplementary Table S2: The percentage of predictions from 28 prediction tools (see Materials and 
Methods) for MVK variants predicting a decrease, increase or neutral change in stability.  Whether 
or not the residue occurs in the structural “hotspot” is also tabulated. 
 
 
 
 
1 
2 
3 Supplementary Table S3:  Predicted severities associated with currently uncharacterised variants. 
4 
5 Variants were predicted to be intermediate/severe  (I/S), mild (M) and mild/neutral (M/N) based on 
6 
7 whether, or not, the altered residue was in the “hotspot” and whether the variant was predicted to 
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be substantially less stable than wild-type. 
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Table 4. Showing the results from all bioinformatic and structural  analysis on known and uncatagorised varinats of MK 
 
 
 
Point Mutati Hydrophobic I-Mutant 3.0   I-Mutant 3.0( I-Mutant 3.0   I-Mutant 3.0   SIFT score      SIFT predictioPROVEAN PR  PROVEAN pr   PolyPhen-2 s PolyPhen-2 p SAM conserv Solvent acces Location in 3  Secondary st  Domain Inter phylopConsS blosum45(Ya Panther_Pde LogR.E-value pfam_eval_mSCORECONS  FOLDX (stabil mCSM protei mCSM predic mCSM Protei mCSM Protei mCSM Protei mCSM Protei SNAP              PANTHER sco PANTHER pre SNP&GO Nali PhD-SNP scorPhD-SNP pre   nsSNPAnalyz nsSNPAnalyz SDM score     SDM predicti Mupro (Kcal/ Mupro predi PoPMuSiC (D PoPMuSiC (R  PoPMuSiC pr  CUPSAT (DDGCUPSAT(RSA) CUPSAT pred iStable  score iStable DDG   iStable predicPredictSNP    PredictSNP p  MAPP             MAPP predic Meta-SNP sc  Meta-SNP pr  GETAREA (ch  GETAREA (ch  SDM change  Sidechain hy   BeAtMuSiC b Binding affini BeAtMuSiC S BeAtMuSiC S FI-mutant assFI prediction  Fathamm sco KD4V size ch   KD4V charge KD4V polarit KD4V hydrop KD4V modific KD4V numbe KD4V WT  res  SNP effect 
HIDS 
V377I -0.118               -0.58 4 (Decrease)  3 (Large decr 6 (neutral) 0.149 Tolerated -0.561 Neutral 0.331 Benign 0.3  0  Buried            Bend               N  - - - - - 0.548               -0.04             -0.871 Destabilizing             -1.467 Destabilizing             -3.393 Destabilizing 1 (Neutral)                  0.251 Neutral 105                0.58 Neutral 0.65 Neutral -0.71 Slightly desta     -0.177581 Decrease 0.72 0.3  Decrease -2.08 0  Decrease              0.628483      -0.116418 Decrease 0.83 Neutral 0.72 Neutral 0.167 Neutral 1.74 14  0  No  Hbonds                  -0.48 Increase 0.31%             0.30% 0.2  Neutral 2.11 Increase         Unchanged    Unchanged    Unchanged 11  1 67  - 
G309S 0.142               -0.91 5 (Decrease)  1 (Neutral)     5 (disease) 0  Damaging                  -5.217 Deleterious 1  Probably dam              0.32                0.61 Exposed         Turn                Y  4.255 -2            0.83724         0.84724         0.00006              0.912                3.31             -0.978 Destabilizing              0.029 Stabilizing                  -0.343 Destabilizing 4 (Non-neutr              0.732 Disease 173                0.88 Deleterious 0.63 Deleterious                 -2.47 Highly destab  -0.9021354 Decrease 1.52              52.78 Decrease 0.05                64.8 Increase               0.698159      -0.948321 Decrease 0.76 Deleterious 0.65 Neutral 0.813 Disease 18.07 4                     -0.4 No  Hbonds 1.07 Decrease                 53.92%           53.92%                3.57 High 1.95 Increase         Unchanged    Increase         Unchanged 22  1 88  Based on  FoldX, the  mutation reduces the  protein stability 
R215Q -0.251               -0.85 8 (Decrease)  3 (Large decr 4 (disease)                  0.109 Tolerated -1.252 Neutral 0.925 Possibly dam                0.28                0.22 Intermediate Beta Ladder  N  - - - - - 0.348                0.56             -1.001 Destabilizing             -0.178 Destabilizing             -3.609 Destabilizing 0 (Non-neutr              0.362 Neutral 177                0.55 Neutral 0.65 Neutral 1.45 Stabilizing an  -1  Decrease 0.96              24.12 Decrease -2.76              24.02 Decrease              0.649136      -0.703575 Decrease 0.65 Neutral 0.78 Neutral 0.362 Neutral -30.24 10                    24.1 No  Hbonds t                    0.09 Decrease                 24.22%           24.22% 1.7  Low 2.27 Decrease       Decrease       Unchanged    Increase 23  1 36  Based on  FoldX, the  mutation slightly reduces the  protein stability  
H20Q -0.086               -0.17 3 (Decrease)  3 (Neutral)     5 (disease) 0  Damaging                  -7.199 Deleterious 1  Probably dam              0.69                0.03 Buried            Turn                N  - - - - - 1                    1.63             -1.334 Destabilizing             -1.203 Destabilizing             -3.642 Destabilizing 5  (Non-neutr- - 167                0.86 Deleterious 0.65 Neutral -2.29 Highly destab  -0.0836759 Decrease 1.23                2.72 Decrease -0.76                2.75 Decrease              0.672123      -0.682095 Decrease 0.87 Deleterious 0.57 Deleterious                0.789 Disease -3.69 4 -2  Saturated to                   -0.09 Increase 2.97%             2.96%                3.75 High 1.4  Decrease       Decrease       Unchanged    Unchanged 25  3 90  Based on  FoldX, the  mutation reduces the  protein stability 
H20N -0.071               -0.47 1 (Decrease)  2 (Neutral)     3 (disease) 0  Damaging                  -6.304 Deleterious 1  Probably dam              0.69                0.03 Buried            Turn                N  - - - - - 1                    2.37             -1.721 Destabilizing             -1.276 Destabilizing             -3.573 Destabilizing 5  (Non-neutr- - 167                0.86 Deleterious 0.65 Neutral -3.27 Highly destab 0.37948357 Increase 1.44                2.72 Decrease -1.92                2.75 Decrease              0.579595         1.05766 Increase 0.87 Deleterious 0.87 Deleterious                0.829 Disease -3.69 4                     -1.9 Saturated to                     0.06 Decrease 2.97%             2.96%                4.09 High 1.41 Decrease       Decrease       Unchanged    Decrease 29  3 90  Based on  FoldX, the  mutation reduces the  protein stability 
L39P 0.232               -1.71 5 (Decrease)  4 (Large decr 6 (disease)                  0.007 Damaging -4.4 Deleterious 1  Probably dam              0.05                0.01 Buried            Beta Ladder  N  - - - - - 0.728                8.83                 -1.7 Destabilizing             -0.337 Destabilizing             -0.171 Destabilizing 0 (Neutral)     -  - 159                0.88 Deleterious 0.63 Deleterious                  -4.04 Highly destab- - - - - - - - - - - 0.76 Deleterious 0.63 Deleterious                0.749 Disease -1.39 20                     -1.3 No  Hbonds 2.25 Decrease 0.26%             0.26%                3.36 Median 2.1  Decrease       Unchanged    Unchanged    Decrease 68  1 44  Based on  FoldX, the  mutation severely reduces the  protein stability  
V132I -0.118               -0.48 5 (Decrease)  4 (Large decr 7 (neutral) 0.301 Tolerated -0.454 Neutral 0.035 Benign 0.29                0.07 Buried            Beta Ladder  N  - - - - - 0.399                1.54             -0.836 Destabilizing             -1.144 Destabilizing              0.052 Stabilizing      1 (Neutral)                  0.298 Neutral 168                0.78 Neutral           -  - -0.26 Neutral and n  -1  Decrease 0.81                5.32 Decrease 0.76                6.51 Increase               0.631072      -0.272555 Decrease 0.83 Neutral 0.66 Neutral 0.13 Neutral 27.72 2                     -2.7 No  Hbonds                  -0.36 Increase 6.08%             6.08%                1.33 Low 2.27 Increase         Unchanged    Unchanged    Unchanged 11  1 23  Based on  FoldX, the  mutation reduces the  protein stability 
A148T 0.166               -0.61 7 (Decrease)  2 (Large decr 3 (neutral) 0.003 Damaging -3.21 Deleterious 1  Probably dam              0.73 0  Buried            Helix               N  4.559 1            0.19768        -0.38535        1.40E-20              0.796                1.61             -1.296 Destabilizing               -1.31 Destabilizing             -0.166 Destabilizing 1 (Non-neutr              0.338 Neutral 177                0.45 Neutral 0.65 Neutral -3.04 Highly destab -1  Decrease 1.28 0  Decrease -4.13 0  Decrease              0.836157      -0.745989 Decrease 0.51 Deleterious 0.59 Deleterious                0.406 Neutral 1.35 8                     -0.6 No  Hbonds 0  - 0%  0%  2.6  Median 1.27 Increase         Unchanged    Increase         Decrease 14  1 71  Based on  FoldX, the  mutation reduces the  protein stability 
P167L -0.232                 -0.9 8 (Decrease)  1 (Large decr 5 (disease)                  0.559 Tolerated -4.53 Deleterious 1  Probably dam              0.02                0.13 Intermediate Turn                N  - - - - - 0.069                6.42             -0.617 Destabilizing             -0.462 Destabilizing             -0.636 Destabilizing 0 (Non-neutr              0.626 Disease 123                0.68 Deleterious 0.65 Neutral 1.97 Stabilizing an     -0.1054934 Decrease 0.98              12.43 Decrease -0.2              12.68 Decrease              0.745859      -0.598328 Decrease 0.55 Deleterious 0.59 Deleterious                0.492 Neutral -8.56 14  0.8  No  Hbonds                  -0.46 Increase 14.31%           14.31%                2.03 Median 2.28 Increase         Unchanged    Unchanged    Increase 68  1 38  Based on  FoldX, the  mutation severely reduces the  protein stability  
G171R 0.501               -0.56 5 (Decrease)  0 (Large decr 3 (disease) 0.15 Tolerated -1.488 Neutral 0.298 Benign 0.04                0.76 Exposed         Turn                N  1.85 -2            0.10391       0.644612        1.50E-19              0.084                3.39             -0.197 Destabilizing              0.052 Stabilizing                  -0.101 Destabilizing 2 (Non-neutr              0.104 Neutral 112                0.68 Neutral           -  - -0.77 Slightly desta   -0.8906818 Decrease 0.77              64.13 Decrease 0.34              81.32 Increase               0.610999      -0.418897 Decrease 0.75 Neutral           -  - 0.309 Neutral -166.18 14                   -17.4 No  Hbonds 0.69 Decrease                 68.67%           68.67% 1.2  Low 2.33 Increase         Increase         Increase         Decrease 61  1 28  Based on  FoldX, the  mutation reduces the  protein stability 
G202R 0.501               -0.56 4 (Decrease)  5 (Neutral)     7 (disease) 0  Damaging                  -7.733 Deleterious 1  Probably dam              0.46                0.07 Buried            Bend               N  4.494 -2            0.92565       0.899885        2.70E-19              0.801 1.8                -0.913 Destabilizing             -1.472 Destabilizing              0.291 Stabilizing      5  (Non-neutr             0.926 Disease 182                0.86 Deleterious 0.63 Deleterious 1.22 Stabilizing an    0.26824473 Increase 1.8                     6.24 Decrease -6.13                7.62 Decrease              0.528534        -1.63173 Decrease 0.87 Deleterious 0.88 Deleterious 0.79 Disease 10.21 24                   -21.4 No  Hbonds 0.4  Decrease 6.25%             6.24%                2.93 Median 1.18 Increase         Increase         Increase         Decrease 61  1 88  Based on  FoldX, the  mutation reduces the  protein stability 
G211E 0.458                 -0.6 2 (Decrease)  2 (Neutral)     7 (disease) 0  Damaging                  -7.656 Deleterious 1  Probably dam              0.04                0.04 Buried            Coil                 N  - - - - - 0.903              18.12             -2.086 Destabilizing             -0.524 Destabilizing             -0.385 Destabilizing 5  (Non-neutr             0.949 Disease 182                0.88 Deleterious 0.63 Deleterious                 -3.71 Highly destab 0.03062227 Increase 3.79                3.97 Decrease -2.8                3.81 Decrease                0.58004       0.907633 Increase 0.87 Deleterious 0.88 Deleterious                0.845 Disease 1.26 10                   -14.3 No  Hbonds t                    1.82 Decrease 5.68%             5.68%                2.84 Median 1.25 Increase         Increase         Increase         Decrease 22  2 90  Based on  FoldX, the  mutation severely reduces the  protein stability  
V250I -0.118               -0.88 9 (Decrease)  6 (Large decr 6 (neutral) 0  Damaging -0.93 Neutral 1  Probably dam                 0.1  0  Buried            Helix               N  - - - - - 1                    0.56             -0.602 Destabilizing               -1.16 Destabilizing             -3.258 Destabilizing 3 (Non-neutr              0.499 Neutral 177                0.73 Deleterious 0.65 Neutral -0.1 Neutral and n  0.05185944 Increase 0.86                0.46 Decrease -1.63 0  Decrease              0.528332      -0.293082 Decrease 0.72 Deleterious 0.63 Neutral 0.714 Disease 1.81 8                     -1.4 No  Hbonds                  -0.37 Increase 0.61%             0.61%                3.31 Median 1.97 Increase         Unchanged    Unchanged    Unchanged 11  1 92  Based on  FoldX, the  mutation slightly reduces the  protein stability  
L265R 0.943               -1.65 8 (Decrease)  5 (Large decr 6 (disease)                  0.002 Damaging                  -4.657 Deleterious 1  Probably dam              0.24                0.05 Buried            Helix               N  3.211 -2            0.65837 - - 0.631                4.65             -1.741 Destabilizing             -1.299 Destabilizing             -0.341 Destabilizing 4 (Non-neutr              0.658 Disease 172                0.86 Deleterious 0.63 Deleterious                 -3.25 Highly destab  -0.7146279 Decrease 1.58                3.11 Decrease -0.07                4.37 Decrease              0.781894        -2.11921 Decrease 0.87 Deleterious 0.88 Deleterious 0.78 Disease -1.66 6                  -13.5 No  Hbonds 0.19 Decrease 3.37%             3.37%                3.08 Median 0.37 Increase         Increase         Increase         Decrease 58  2 51  Based on  FoldX, the  mutation reduces the  protein stability 
G326R 0.501               -0.33 2 (Decrease)  5 (Neutral)     5 (disease) 0.17 Tolerated -3.893 Deleterious 1  Probably dam              0.02                0.46 Exposed         Turn                N  4.255 -2            0.15811       0.608793       0.000026              0.622                2.14             -0.803 Destabilizing             -1.202 Destabilizing             -3.262 Destabilizing 3 (Non-neutr              0.158 Neutral 172                0.86 Deleterious 0.63 Deleterious                 -1.53 Destabilizing   0.48878028 Increase 1.27              32.92 Decrease -4.3              49.56 Decrease              0.548191      -0.473804 Decrease 0.61 Deleterious 0.64 Neutral 0.6  Disease -157.68 14                   -19.1 No  Hbonds t                   -0.04 Increase 31.79%           31.78% -  - -1.26 Increase         Increase         Increase         Decrease 61  1 63  Based on  FoldX, the  mutation reduces the  protein stability 
G376V -0.324               -0.43 5 (Decrease)  0 (Neutral)     2 (disease) 0  Damaging                  -7.628 Deleterious 1  Probably dam              0.05 0  Buried            Coil                 N  4.517 -  - - - 0.921              20.24             -0.532 Destabilizing               -1.03 Destabilizing               -2.83 Destabilizing 4 (Non-neutr              0.994 Disease 110                0.88 Deleterious 0.63 Deleterious 1.04 Stabilizing an    0.87302453 Increase 1.57 0  Decrease -9.17 0  Decrease              0.602486      -0.430549 Decrease 0.87 Deleterious 0.76 Deleterious                0.871 Disease 11.79 10                     -0.2 No  Hbonds 0.56 Decrease 0%  0%                     2.96 Median 1.78 Increase         Unchanged    Unchanged    Increase 44  1 88  Based on  FoldX, the  mutation severely reduces the  protein stability  
S135L -0.584               -0.14 6 (Decrease)  3 (Neutral)     5 (disease)                  0.001 Damaging                  -5.499 Deleterious 1  Probably dam              0.05                0.13 Intermediate Beta Ladder  N  - - - - - 0.909               -0.97             -0.063 Destabilizing             -0.479 Destabilizing             -0.318 Destabilizing 4 (Non-neutr              0.707 Disease 176                0.88 Deleterious 0.63 Deleterious 2.84 Highly stabili 1  Increase 0.46                15.6 Decrease 1.55              14.51 Increase               0.521752       0.157841 Increase 0.87 Deleterious 0.76 Deleterious 0.76 Disease 33.16 24  9.8  No  Hbonds                  -0.56 Increase 15.03%           15.02%                2.99 Median 2.14 Increase         Unchanged    Decrease       Increase 45  1 86  Based on  FoldX, the  mutation slightly enhances the  protein stability  
L117P 0.221               -1.49 5 (Decrease)  4 (Large decr 7 (disease)                  0.084 Tolerated -4.242 Deleterious 1  Probably dam- - Helix               -  0.393                9.66             -1.353 Destabilizing             -0.796 Destabilizing             -0.001 Destabilizing 2 (Neutral) 0.74 Disease 145                0.88 Deleterious 0.63 Deleterious                  -4.85 Highly destab- - - - - - - - - - - 0.61 Deleterious 0.62 Deleterious                0.767 Disease -24.64 28                     -8.4 No  Hbonds 0.45 Decrease 4.15%             4.14%                3.05 Median 2.25 Decrease       Unchanged    Unchanged    Decrease 68  0 38  Based on  FoldX, the  mutation severely reduces the  protein stability  
I119M 0.205               -1.51 7 (Decrease)  4 (Large decr 0 (neutral) 0.003 Damaging                  -2.225 Neutral 0.959 Probably dam              0.03                0.03 Buried            Helix               N  - - - - - 0.172                0.82             -0.628 Destabilizing             -1.562 Destabilizing              0.052 Stabilizing      5 (Neutral)                  0.299 Neutral 147                0.55 Neutral 0.65 Neutral -0.3 Neutral and n-  - - - - - - - - - - 0.61 Deleterious 0.57 Deleterious                0.493 Neutral -2.74 0 0.7  No  Hbonds -0.4 Increase 1.38%             1.38%                3.12 Median 2.19 Increase         Unchanged    Unchanged    Unchanged 7 1 40  Based on  FoldX, the  mutation slightly reduces the  protein stability  
Y116H 0.715                 -1.3 7 (Decrease)  3 (Large decr 6 (disease)                  0.008 Damaging                  -4.216 Deleterious 1  Probably dam                 0.1  0  Buried            Helix               N  2.948 2            0.52761 - - 0.46                3.73             -0.795 Destabilizing             -0.564 Destabilizing              0.332 Stabilizing      1 (Non-neutr              0.528 Disease 145                0.73 Deleterious 0.63 Deleterious                 -0.95 Slightly desta -1  Decrease 2.78 0  Decrease -5.97 0  Decrease              0.772159        -1.58913 Decrease 0.87 Deleterious 0.77 Deleterious                0.698 Disease -0.86 22  0.1  No  Hbonds 1.05 Decrease 0%  0%                     3.21 Median 1.29 Unchanged    Increase         Unchanged    Decrease 49  1 42  Based on  FoldX, the  mutation reduces the  protein stability and based on  TANGO the  mutation decreases the  aggregation tendency of the  protein 
G211A -0.115               -0.91 5 (Decrease)  0 (Large decr 5 (disease)          0  Damaging                  -5.689 Deleterious 1  Probably dam              0.04                0.04 Buried            Coil                 N                 2.704  -2            0.94854       0.866461        2.50E-19              0.903 7.6                -0.843 Destabilizing             -0.035 Destabilizing             -0.313 Destabilizing 4 (Non-neutr              0.891 Disease 182                0.88 Deleterious 0.63 Deleterious                 -2.19 Highly destab  -0.0794474 Decrease     2.5                     3.97 Decrease -3.88                3.81 Decrease              0.686492      -0.686381 Decrease 0.87 Deleterious 0.77 Deleterious                0.769 Disease     1.12 2                     -2.4 No  Hbonds 0.78 Decrease 5.68%             5.68% 1.6  Low 2.29 Unchanged    Unchanged    Unchanged    Increase 14  2 90  Based on  FoldX, the  mutation severely reduces the  protein stability 
V203A 0.209               -1.67 9 (Decrease)  5 (Large decr 0 (neutral) 0.002 Damaging -3.8 Deleterious 1  Probably dam              0.78                0.11 Intermediate Helix               N                 3.735  -3            0.81093       2.012589        3.50E-18              0.712                0.96               -1.62 Destabilizing             -0.895 Destabilizing             -0.274 Destabilizing 0 (Neutral)                  0.527 Disease 182                0.59 Deleterious 0.65 Neutral -0.81 Slightly desta -1  Decrease 1.87                7.14 Decrease -1.61                9.76 Decrease              0.790729        -1.22263 Decrease 0.61 Deleterious 0.78 Deleterious                0.461 Neutral -13.79 4                     -8.3 No  Hbonds 0.57 Decrease 8.21%             8.21% 1.6  Low 2.29 Decrease       Unchanged    Unchanged    Unchanged 33  1 40  Based on  FoldX, the  mutation slightly reduces the  protein stability 
L246P 0.221               -1.79 6 (Decrease)  6 (Large decr 7 (disease)                  0.001 Damaging                  -6.033 Deleterious 1  Probably dam              0.11                0.19 Intermediate Helix               N  - -        -  - - 0.831                2.73             -1.457 Destabilizing             -0.576 Destabilizing             -2.587 Destabilizing 3 (Non-neutr                0.88 Disease 180                0.88 Deleterious 0.63 Deleterious   -3.7 Highly destab -1  Decrease 3.33              16.31 Decrease -3.33              16.93 Decrease              0.730036        -1.72421 Decrease 0.87 Deleterious 0.81 Deleterious                0.755 Disease     6.62 6 4  No  Hbonds 1.61 Decrease                 15.80%           15.79%                3.24 Median 2.05 Decrease       Unchanged    Unchanged    Decrease 68  1 73  Based on  FoldX, the  mutation reduces the  protein stability 
V261A                         0.209                 -1.7 9 (Decrease)  5 (Large decr 4 (neutral)                  0.008 Damaging                  -2.505 Deleterious                0.827 Possibly dam -                            -                                                         Helix               -                            -                            -                            -                            -                            -                                           0.526                   2.1                  1.697 Destabilizing             -0.667 Destabilizing             -0.717 Destabilizing 2 (Neutral)                  0.649 Disease                           174                0.68 Neutral           -                            -                                            -1.53 Destabilizing                     -1  Decrease                       2.16                0.61 Decrease                     -0.41                0.65 Decrease              0.759876        -1.34816 Decrease                       0.65 Neutral                          0.46 Deleterious                0.162 Neutral                        -5.57                    40                     -2.5 No  Hbonds                   0.59 Decrease                    3.65%             0.91%                2.55 Median                          2.27 Decrease       Unchanged    Unchanged    Unchanged                      33                           0                        32  Based on  FoldX, the  mutation reduces the  protein stability 
A262P                        -0.095               -0.06 6 (Increase)   3 (Large decr 6 (disease)                  0.129 Tolerated                  -1.212 Neutral                          0.71 Possibly dam -                            -                                                         Helix               -                            -                            -                            -                            -                            -                                           0.436                3.55               -0.42 Destabilizing             -1.192 Destabilizing             -0.468 Destabilizing 5 (Neutral)                  0.458 Neutral                           172                0.82 Deleterious                   0.65 Neutral                        -2.22 Highly destab  -0.5774476 Decrease                       1.43                38.1 Decrease                       0.37              40.83 Increase               0.629401        -0.70117 Decrease                         0.6  Neutral                          0.46 Deleterious                0.511 Disease                          7.11                    10                    25.2 No  Hbonds                   0.38 Decrease                 38.10%           38.10%                2.05 Median                          2.25 Increase         Unchanged    Unchanged    Decrease                          15                           0                        25  Based on  FoldX, the  mutation reduces the  protein stability 
R277C                          -0.68                 -0.8 4 (Decrease)  1 (Neutral)     5 (disease)                  0.015 Damaging                  -2.863 Deleterious                        1  Probably dam                 0.1                     0.51 Exposed         Helix               N                                         2.099                     -3            0.67461 -                            -                                           0.507                1.01             -0.371 Destabilizing             -0.181 Destabilizing              2.021 Stabilizing      1 (Neutral)                  0.675 Disease                           171                0.66 Neutral                          0.65 Neutral                        -0.21 Neutral and n   -0.6846569 Decrease                       1.17              47.17 Decrease                       0.85              55.46 Increase               0.667106        -0.57655 Decrease                       0.61 Deleterious                   0.51 Deleterious                0.425 Neutral                          24.8                    10                   -22.8 No  Hbonds t                    0.71 Decrease                 47.46%           47.46%                2.47 Median                          2.01 Decrease       Decrease       Decrease       Increase                            77                           2                        30  Based on  FoldX, the  mutation reduces the  protein stability 
R277H -0.165               -1.22 9 (Decrease)  3 (Large decr 4 (disease)                  0.069 Tolerated -1.978 Neutral 0.231 Benign 0.1                     0.51 Exposed         Helix               N  2.099 -  - - - 0.507                0.93             -1.139 Destabilizing                0.31 Stabilizing 0.308 Stabilizing      7 (Neutral)                  0.346 Neutral 171                0.83 Neutral 0.65 Neutral -0.49 Neutral and n   -0.5495372 Decrease 0.47              47.17 Decrease -0.4              55.46 Decrease 0.7562      -0.505408 Decrease 0.83 Neutral 0.72 Neutral 0.166 Neutral 24.8 10                   -23.5 No  Hbonds t                    0.18 Decrease                 47.46%           47.46%                2.47 Median 2.04 Decrease       Unchanged    Unchanged    Increase 14  2 30  Based on  FoldX, the  mutation slightly reduces the  protein stability  
P288L -0.232               -0.14 2 (Decrease)  6 (Large incre1 (disease)                  0.387 Tolerated -1.875 Neutral 0.001 Benign 0.04                 0.72 Exposed         Helix               N  - - - - - 0.236                1.37             -0.332 Destabilizing             -0.653 Destabilizing             -0.774 Destabilizing 1 (Neutral)                  0.219 Neutral 142                0.78 Neutral 0.65 Neutral 0.54 Slightly stabil  0.28645925 Increase 0.42              66.42 Decrease 0.2                  69.06 Increase               0.523442       0.247829 Increase 0.83 Neutral 0.63 Neutral 0.154 Neutral -7.46 4 5.8  No  Hbonds 0.3  Decrease                 69.15%           69.14%                1.39 Low 2.28 Increase         Unchanged    Unchanged    Increase 68  1 32  Based on  FoldX, the  mutation reduces the  protein stability 
V293M 0.087               -0.72 5 (Decrease)  1 (Neutral)     2 (neutral) 0.057 Tolerated -0.975 Neutral 0.998 Probably dam              0.02                0.11 Intermediate Helix               N  0.035 1               0.2051       0.685182        6.40E-06              0.394                0.13             -0.397 Destabilizing             -1.301 Destabilizing             -0.051 Destabilizing 4 (Neutral)                  0.205 Neutral 155                0.78 Neutral 0.65 Neutral 0.98 Slightly stabil   -0.5732895 Decrease 0.67                8.97 Decrease -0.95                9.76 Decrease              0.832125      -0.325591 Decrease 0.74 Neutral 0.76 Neutral 0.192 Neutral 14.52 2                  -16.6 No  Hbonds 0.02 Decrease                 24.62%           10.33%                1.75 Low 2.26 Increase         Unchanged    Unchanged    Unchanged 16  1 28  - 
I298T 0.493               -1.94 8 (Decrease)  2 (Large decr 5 (disease)                  0.007 Damaging                  -2.984 Deleterious                0.962 Probably dam- - Helix               -  - - - - - 0.725                2.39 -3  Destabilizing             -0.944 Destabilizing             -1.209 Destabilizing 0 (Non-neutr                0.36 Neutral 171                0.58 Neutral           -  - -4.03 Highly destab -1  Decrease 1.96                3.18 Decrease -3.9                3.24 Decrease -3.9                3.24 Decrease 0.61 Deleterious 0.51 Deleterious                0.432 Neutral -33.42 12  1.1  No  Hbonds 0.57 Decrease 4.14%             4.14%                2.96 Median 2.12 Decrease       Unchanged    Increase         Decrease 29  0 32  Based on  FoldX, the  mutation reduces the  protein stability 
V310L -0.118               -0.85 7 (Decrease)  1 (Neutral)     1 (disease)  0  Damaging                  -2.675 Deleterious  1  Probably dam              0.38                0.01 Buried            Coil                 N               2.755 1            0.57634       0.339948       0.000014              0.874                 -0.3             -0.701 Destabilizing             -0.868 Destabilizing             -2.744 Destabilizing 5  (Non-neutr             0.576 Disease  173                0.88 Deleterious 0.65 Neutral              0.73 Slightly stabil   -0.1842745 Decrease  0.56                0.91 Decrease  0.51 1.3  Increase               0.736531      -0.188765 Decrease  0.87 Deleterious  0.62 Deleterious                0.667 Disease              7.95 20                     -0.8 No  Hbonds                  -0.54 Increase   1.22%             1.22%                2.63 Median  1.71 Increase         Unchanged    Unchanged    Unchanged  21  1 90  - 
Average           0.08054839    -0.9009677 0.07164516 -3.7381613 0.84764516 0.22481481   0.17925926 3.10828571    -1.0833333     0.5520075   0.72437333    1.1822E-05   0.62409677                3.64    -0.9241935 -0.7866452 -1.0358065 0.53410714 161.580645   0.76354839 0.65 -1.1596774 -0.3622991 1.44142857   16.6703571 -1.5433333   22.1883333 0.50453246    -0.4532709 0.74967742 0.68666667 0.55025806 -8.6303226   11.6129032    -3.5451613 0.35612903 16.37%           15.82%            2.5025 1.81032258 36.9677419   1.16129032   56.6129032 
INTERMEDIATE 
I268T 0.493               -2.19 9 (Decrease)  6 (Large decr 3 (disease)                  0.003 Damaging                  -3.863 Deleterious                0.888 Possibly dam                0.06                0.01 Buried            Helix               Y  3.211 -  - - - 0.65                1.26             -2.975 Destabilizing             -0.516 Destabilizing             -0.422 Destabilizing 2 (Non-neutr              0.681 Disease 176                0.68 Deleterious 0.65 Neutral -4.03 Highly destab -1  Decrease 2.3                     0.41 Decrease -0.61                1.08 Decrease                0.80173        -2.56071 Decrease 0.87 Deleterious 0.57 Deleterious                0.736 Disease -0.59 6                     -0.6 No  Hbonds 1.03 Decrease 0.55%             0.55%                2.87 Median 2.18 Decrease       Unchanged    Increase         Decrease 29  1 67  Based on  FoldX, the  mutation reduces the  protein stability 
H20P -0.546                0.41 6 (Increase)   2 (Large incre5 (disease) 0  Damaging                  -8.956 Deleterious 1  Probably dam              0.69                0.03 Buried            Turn                N  - - - - - 1                    1.62               -0.79 Destabilizing               -1.35 Destabilizing             -3.415 Destabilizing 4 (Non-neutr -  - 167                0.88 Deleterious 0.65 Neutral -2.03 Highly destab  -0.1762532 Decrease 1.97                2.72 Decrease -5.45                2.75 Decrease              0.566879      -0.974564 Decrease 0.87 Deleterious 0.84 Deleterious                0.859 Disease -57.06 6                     -9.6 Saturated to                     0.42 Decrease 2.97%             2.96%                4.09 High 1.4  Decrease       Decrease       Decrease       Decrease 57  3 90  Based on  FoldX, the  mutation reduces the  protein stability 
S272F -0.641 0.2  1 (Increase)   3 (Neutral)     6 (disease)                  0.002 Damaging                  -4.273 Deleterious                0.998 Probably dam              0.16 0  Buried            Helix               N  - - - - - 0.517 5.2                -0.794 Destabilizing             -0.881 Destabilizing             -4.893 Destabilizing 0 (Non-neutr              0.854 Disease 173                0.61 Deleterious 0.65 Neutral 3.03 Highly stabili   0.25059202 Increase -0.28 0  Increase 3.68 0  Increase               0.767788       0.685235 Increase 0.87 Deleterious 0.59 Deleterious                0.567 Disease 0.31 18  0  No  Hbonds                  -1.57 Increase 0%  0%                     3.13 Median 2.29 Increase         Unchanged    Decrease       Increase 63  1 51  Based on  FoldX, the  mutation severely reduces the  protein stability  
R241C        -0.68               -1.05 5 (Decrease)  1 (Neutral)     5 (disease)  0  Damaging                  -7.267 Deleterious              1  Probably dam-- None              -  - - - - -        0.632               -0.05             -0.824 Destabilizing             -0.635 Destabilizing             -1.315 Destabilizing 4 (Non-neutr              0.945 Disease     178                0.88 Deleterious 0.65 Neutral 1.55 Stabilizing an     -0.3632834 Decrease  0.3                  24.71 Decrease   -0.12              27.51 Decrease              0.558955      -0.198894 Decrease 0.87 Deleterious     0.91 Deleterious                0.818 Disease -112.24 10  -19  Unsaturated               -0.35 Increase 25.59%           25.59%                3.22 Median 1.97 Decrease       Decrease       Decrease       Increase  77  0 65  - 
Average -0.3435          -0.6575 0.00125 -6.08975 0.9715 0.30333333   0.01333333                 3.211     0.69975            2.0075        -1.34575 -0.8455 -2.51125 0.82666667 173.5            0.7625 0.65 -0.37 -0.3222361 1.0725                6.96 -0.625              7.835 0.673838    -0.7622333 0.87 0.7275 0.745 -42.395 10                     -7.3 -0.1175   7.28%             7.28%            3.3275 1.96 56.5                1.25              68.25 
MA 
A334T                          0.166               -0.26 2 (Increase)   0 (Large decr 5 (disease)                  0.002 Damaging                  -3.431 Deleterious                        1  Probably dam              0.93                0.09 Intermediate Bend               N                                         4.255                      1            0.58355         1.49485            0.0002                      1                    1.15                 -1.3 Destabilizing             -0.127 Destabilizing             -0.552 Destabilizing 3 (Non-neutr              0.639 Disease                           171                0.82 Deleterious                   0.65 Neutral                           -0.1 Neutral and n   -0.5027285 Decrease                       0.57              10.37 Decrease                     -3.62                9.07 Decrease              0.608033        -0.58267 Decrease                       0.87 Deleterious                   0.84 Deleterious                0.726 Disease                          2.66                      4                           7  No  Hbonds                  -0.43 Increase                     9.32%             9.31%                3.38 Median                          0.89 Increase         Unchanged    Increase         Decrease                          14                           1                        86  Based on  FoldX, the  mutation reduces the  protein stability 
T243I                          -0.493               -0.93 9 (Decrease)  4 (Large decr 1 (neutral)                          0  Damaging                      -5.6 Deleterious                0.996 Probably dam              0.14                0.52 Exposed         Helix               N                          -                            -                            -                            -                            -                                                    1                  -0.73             -0.197 Destabilizing             -0.284 Destabilizing             -1.005 Destabilizing 4 (Non-neutr              0.913 Disease                           179                0.88 Deleterious                   0.65 Neutral                          2.79 Highly stabili    -0.3441432 Decrease                       0.19              42.46 Decrease                       1.38              53.35 Increase               0.541203       0.182661 Increase                        0.87 Deleterious                   0.82 Deleterious                0.849 Disease                          2.09                      4                     -2.5 No  Hbonds                   0.02 Decrease                 46.23%           46.23%                3.32 Median                          1.63 Increase         Unchanged    Decrease       Increase                            29                           1                        92  Based on  FoldX, the  mutation slightly enhances the  protein stability 
N301T                        -0.214                      0  1 (Decrease)  1 (Neutral)     3 (disease)                  0.003 Damaging                          -5  Deleterious                        1  Probably dam              0.05                      0  Buried            Helix               N                                         3.469                     -2            0.85882         2.14321         0.00089              0.915               -0.58             -1.757 Destabilizing             -1.127 Destabilizing             -0.877 Destabilizing 4 (Non-neutr              0.685 Disease                           173                0.88 Deleterious                   0.63 Deleterious                     1.1  Stabilizing an     -0.7445981 Decrease                       0.02                      0  Decrease                     -2.57                      0  Decrease              0.783536      -0.133177 Decrease                       0.87 Deleterious                   0.59 Deleterious                0.802 Disease                          -4.2                    12                           0  Unsaturated               -1.31 Increase                           0%                       0%                     2.56 Median                          2.04 Decrease       Unchanged    Unchanged    Increase                            24                           1                        86  Based on  FoldX, the  mutation slightly enhances the  protein stability 
L264F                         -0.057               -1.14 7 (Decrease)  5 (Large decr 3 (disease)                  0.005 Damaging                  -2.494 Neutral                        0.985 Probably dam                 0.1                     0.01 Buried            Helix               Y                           -                            -                            -                            -                            -                                           0.731                9.02             -1.498 Destabilizing             -1.213 Destabilizing             -0.459 Destabilizing 1 (Non-neutr              0.543 Disease                           170                0.66 Neutral                          0.63 Deleterious                 -0.29 Neutral and n                       -1  Decrease                       1.15                0.39 Decrease                       0.51                0.55 Increase               0.787553      -0.757825 Decrease                         0.6  Neutral                          0.57 Deleterious                0.444 Neutral                      -16.66                    24                   -25.1 No  Hbonds                   0.39 Decrease                 15.80%             0.78%                1.93 Median                          2.18 Increase         Unchanged    Unchanged    Unchanged                      28                           1                        25  Based on  FoldX, the  mutation severely reduces the  protein stability 
L265P                          0.232               -1.56 6 (Decrease)  5 (Large decr 5 (disease)                  0.003 Damaging                  -5.387 Deleterious                        1  Probably dam              0.24                0.05 Buried            Helix               N                          -                            -                            -                            -                            -                                           0.631                7.34             -1.417 Destabilizing             -0.972 Destabilizing             -0.832 Destabilizing 4 (Non-neutr              0.733 Disease                           172                0.88 Deleterious                   0.63 Deleterious                 -4.85 Highly destab                   -1  Decrease                       3.61                3.11 Decrease                     -0.26                4.37 Decrease              0.800747        -2.13331 Decrease                       0.87 Deleterious                   0.86 Deleterious                0.796 Disease                      -24.17                    14                     -3.5 No  Hbonds                   1.83 Decrease                    3.37%             3.37%                3.06 Median                          1.98 Decrease       Unchanged    Unchanged    Decrease                          68                           2                        51  Based on  FoldX, the  mutation severely reduces the  protein stability 
I268H                           0.778               -2.27 9 (Decrease)  7 (Large decr 4 (disease)                          0  Damaging                  -5.832 Deleterious                0.999 Probably dam              0.06                0.01 Buried            Helix               Y                                          3.211 -                            -                            -                            -                                              0.65                6.71             -2.444 Destabilizing             -0.287 Destabilizing             -0.286 Destabilizing 5  (Non-neutr             0.905 Disease                           176                0.73 Deleterious                   0.65 Neutral                        -1.98 Destabilizing                     -1  Decrease                       1.61                0.41 Decrease                         1.2                     1.08 Increase               0.692282        -2.16412 Decrease                       0.87 Deleterious                   0.75 Deleterious                0.772 Disease                        -8.11                      6                           0  No  Hbonds t                    0.35 Decrease                    0.55%             0.55% -                            -                                              2.12 Increase         Unchanged    Increase         Decrease                          42                           1                        67  Based on  FoldX, the  mutation severely reduces the  protein stability  
R241H                         0.451                 -1.4 9 (Decrease)  4 (Large decr 6 (disease)                          0  Damaging                  -4.533 Deleterious                        1  Probably dam-                       -                                                         None              -                            -                            -                            -                            -                            -                                           0.631               -0.06             -1.481 Destabilizing               -0.07 Destabilizing             -1.152 Destabilizing 0 (Neutral)                  0.796 Disease                           178                0.88 Deleterious                   0.65 Neutral                          0.28 Neutral and n   -0.6639918 Decrease                         0.1                  24.71 Decrease                     -0.27              27.51 Decrease              0.691215      -0.219187 Decrease                       0.76 Deleterious                   0.75 Deleterious                0.629 Disease                    -112.24                    10                   -18.8 Unsaturated                  -0.6 Increase                   25.59%           25.59%                3.22 Median                          2.09 Decrease       Unchanged    Unchanged    Increase                            14                           0                        65  - 
V310M 0.087               -0.57 2 (Decrease)  3 (Neutral)     4 (disease)          0  Damaging                  -2.625 Deleterious        1  Probably dam              0.38                0.01 Buried            Coil                 N  2.755   1            0.79025        -0.09861 5.1E-0.6 0.874                0.94               -0.66 Destabilizing             -0.804 Destabilizing             -2.675 Destabilizing 4 (Non-neutr                0.79 Disease 173                0.88 Deleterious 0.65 Neutral 0.79 Slightly stabil   -0.6666272 Decrease 1.02                0.91 Decrease -0.18 1.3  Decrease              0.787094      -0.481615 Decrease 0.87 Deleterious 0.75 Deleterious                0.841 Disease  8.18     8  0.8  No  Hbonds                  -0.16 Increase 1.22%             1.22%                3.88 High   1.6  Increase         Unchanged    Unchanged    Unchanged 16  1 90  Based on  FoldX, the  mutation slightly reduces the  protein stability 
V8M 0.087               -1.35 8 (Decrease)  3 (Large decr 1 (neutral) 0.003 Damaging 2.131 Neutral 0.99 Probably dam              0.05 0  Buried            Beta Ladder  N  3.014   1  - - - 0.638               -0.57             -1.106 Destabilizing               -1.27 Destabilizing             -3.673 Destabilizing 2 (Non-neutr -  - 113                0.59 Deleterious 0.65 Neutral -0.88 Slightly desta     -0.370241 Decrease 1.76                0.15 Decrease -1.84     0  Decrease              0.624005        -1.60117 Decrease 0.87 Deleterious 0.57 Deleterious                0.282 Neutral  0.22     4                     -0.1 No  Hbonds 0.37 Decrease  0%  0%                     2.94 Median 2.01 Increase         Unchanged    Unchanged    Unchanged 16  1 61  Based on  FoldX, the  mutation slightly enhances the  protein stability 
L35S 0.584               -2.31 9 (Decrease)  6 (Large decr 6 (disease)          0  Damaging                  -5.157 Deleterious        1  Probably dam              0.16                0.08 Buried            Beta Ladder  N  3.906 -3  - - - 0.797                3.08               -2.72 Destabilizing              0.289 Stabilizing                  -0.242 Destabilizing 1 (Neutral)     - - 163                0.88 Deleterious 0.63 Deleterious                 -3.04 Highly destab -1  Decrease     2.1                     8.54 Decrease -2.26 7.1  Decrease              0.871305        -1.53066 Decrease 0.76 Deleterious 0.59 Deleterious                0.677 Disease  -59  14                    13.4 No  Hbonds 0.75 Decrease 8.03%             8.03%                3.26 Median 1.97 Decrease       Unchanged    Increase         Decrease 45  1 80  Based on  FoldX, the  mutation reduces the  protein stability 
L234P 0.232               -1.66 5 (Decrease)  6 (Large decr 5 (disease)                  0.001 Damaging                  -5.899 Deleterious 1  Probably dam              0.36                0.04 Buried            Beta Ladder  N  - - - - - 0.623                9.38             -1.736 Destabilizing             -0.784 Destabilizing              3.177 Stabilizing      1 (Neutral)                  0.937 Disease 179                0.88 Deleterious 0.63 Deleterious                 -4.04 Highly destab -1  Decrease 2.92                2.85 Decrease -2.86                3.82 Decrease              0.752253        -1.34593 Decrease 0.87 Deleterious 0.84 Deleterious                0.797 Disease -44.29 26  -12  No  Hbonds 0.74 Decrease 2.85%             2.85% 3.1  Median 1.8  Decrease       Unchanged    Unchanged    Decrease 68  1 59  Based on  FoldX, the  mutation severely reduces the  protein stability  
G338D 0.473               -0.45 2 (Increase)   3 (Neutral)     7 (disease) 0  Damaging                  -6.125 Deleterious 1  Probably dam- - Bend               -  - - - - - 1                    3.35             -2.417 Destabilizing               -0.83 Destabilizing             -0.748 Destabilizing 6 (Non-neutr              0.746 Disease 170                0.88 Deleterious 0.63 Deleterious                 -3.17 Highly destab  -0.0109465 Decrease 2.05                6.24 Decrease 1.06                7.62 Increase               0.597625        -1.26047 Decrease 0.87 Deleterious 0.88 Deleterious                0.843 Disease 7.94 16                     -4.6 No  Hbonds 0.56 Decrease 6.81%             6.81%                2.89 Median -0.1 Increase         Increase         Increase         Decrease 28  0 92  Based on  FoldX, the  mutation reduces the  protein stability 
Avergae           0.19383333    -1.1583333 0.00141667 -4.1626667 0.9975 0.247              0.081 3.435                 -0.4   0.74420667   1.17981667       0.000545   0.79083333            3.2525    -1.5610833 -0.62325 -0.777 0.7687 168.083333                0.82 0.64 -1.1158333 -0.6919397 1.425              8.345 -0.8091667            9.6475 0.71140425    -1.0022894 0.82916667 0.73416667 0.70483333 -20.631667   11.8333333    -3.7833333 0.20916667 9.98%             8.73%   3.04909091 1.68416667 32.6666667   0.91666667   71.1666667 
UNKNOWNS 
S52N 0.123               -0.77 4(Decrease)  3(Neutral)      3 (neutral) 1  Tolerated 1.102 Neutral 0  Benign 0.25                0.06 Buried            Beta Ladder  N  - - - - - 0.484               -0.51             -0.991 Destabilizing             -0.258 Destabilizing             -0.055 Destabilizing 0 (Neutral)     -  - 157                0.83 Neutral           -  - -0.27 Neutral and n   -0.8182978 Decrease 0.64              15.22 Decrease 0.55                6.83 Increase               0.707038      -0.694075 Decrease 0.83 Neutral 0.85 Neutral 0.122 Neutral 10.21 4                     -2.1 No  Hbonds t                   -0.34 Increase 11.56%           11.56%               -1.07 Neutral 2.29 Increase         Unchanged    Unchanged    Decrease 15  1 13  Based on  FoldX the  mutation slightly enhances the  protein stability  
T356M -0.288                0.13 1 (Increase)   0(Large decre4 (neutral)  0.134 Tolerated 0.132 Neutral 0.621 Possibly dam                0.23                0.01 Buried            Helix               N  - - - - - 0.436               -0.17              0.119 Stabilizing                  -0.752 Destabilizing              0.159 Stabilizing      1 (Neutral)                  0.194 Neutral 128                0.89 Neutral           -  - 1.77 Stabilizing an     -0.5213254 Decrease -0.16                0.49 Increase -0.08                1.44 Decrease              0.590477       0.125546 Increase 0.83 Neutral 0.64 Neutral 0.107 Neutral 0 2                     -1.6 Saturated to                   -1.17 Increase 0.99%             0.98% 0.9  Low 2.31 Increase         Unchanged    Decrease       Increase 32  1 13  - 
H24P -0.546                0.52 6 (Increase)   2(Large decre5 (disease)                  0.003 Damaging                  -7.697 Deleterious                0.998 Probably dam              0.39                0.26 Intermediate 3/10 Helix      N  - - - - - 0.675                0.64              0.299 Stabilizing                  -1.223 Destabilizing                 -2.6 Destabilizing 4 (Non-neutr -  - 167                0.86 Deleterious 0.65 Neutral -2.72 Highly destab     -0.017423 Decrease 2.56              23.58 Decrease -0.97              25.84 Decrease              0.668177      -0.686846 Decrease 0.87 Deleterious 0.84 Deleterious                0.788 Disease -80.06 6                     -0.1 No  Hbonds 1.33 Decrease                 23.21%           23.21%                3.34 Median 2.49 Decrease       Decrease       Decrease       Decrease 57  1 48  Based on  FoldX the  mutation slightly reduces the  protein stability  
R124W -0.878               -0.46 5 (Decrease)  0(Large decre6 (disease)                  0.017 Damaging                  -2.525 Deleterious                0.952 Possibly dam - - - - - - - - - 0.29                0.07             -0.555 Destabilizing             -0.172 Destabilizing                0.13 Stabilizing      0 (Non-neutr              0.816 Disease 133                0.58 Neutral 0.65 Neutral 1.44 Stabilizing an     -0.1441623 Decrease 0.29              97.75 Decrease -0.5            114.14 Decrease              0.784403      -0.263238 Decrease 0.63 Neutral 0.65 Neutral 0.603 Disease -21.56 6 1.7  Saturated 0.37 Decrease 100%              100%                1.52 Low 2.23 Unchanged    Decrease       Decrease       Increase 54  0 30  - 
I56V 0.118               -1.12 8(Decrease)  6(Large decre6 (neutral)  0.355 Tolerated -0.629 Neutral 0  Benign 0.14                0.47 Exposed         Turn                N  - - - - - 0.627                1.17             -0.533 Destabilizing             -0.664 Destabilizing             -0.464 Destabilizing 3 (Neutral)     - - 152                0.66 Neutral           -  - -0.74 Slightly desta   -0.4200442 Decrease 0.23              42.82 Decrease -0.95                42.7 Decrease              0.824867    -0.0065668 Decrease 0.83 Neutral 0.71 Neutral 0.199 Neutral -6.62 2                    15.4 No  Hbonds                  -0.11 Increase 40.34%           40.33%                1.42 Low 2.24 Decrease       Unchanged    Unchanged    Unchanged 11  1 44  Based on  FoldX the  mutation reduces the  protein stability 
R60W -0.878               -0.42 6(Decrease)  1(Neutral)      6 (disease)                  0.084 Tolerated -1.889 Neutral 0.059 Benign 0.04                0.23 Intermediate Beta Ladder  N  - - - - - 0.076               -0.81             -0.304 Destabilizing             -0.678 Destabilizing                 -0.4 Destabilizing 1 (Neutral)     -  - 141                0.59 Deleterious   -  - 5.18 Highly destab  -0.9310868 Decrease -0.63              27.93 Increase -0.54              24.89 Decrease                0.51972       0.186462 Increase 0.63 Neutral 0.64 Neutral 0.426 Neutral -40.15 20                    29.2 Saturated -1.11 Increase 24.22%           24.22%                2.21 Median 2.3  Unchanged    Decrease       Decrease       Increase 54  0 25  Based on  FoldX the  mutation slightly enhances the  protein stability  
V160L -0.118               -0.94 8(Decrease)  2(Large decre3 (neutral)  0.655 Tolerated -0.082 Neutral 0  Benign 0.09                0.25 Intermediate Helix               N  - - - - - 0.418                0.59             -0.552 Destabilizing             -0.369 Destabilizing             -0.198 Destabilizing 7 (Neutral)                  0.238 Neutral 153                0.83 Neutral           -  - 1.1  Stabilizing an    0.46820498 Increase 0.29              18.84 Decrease -1.6              22.77 Decrease              0.596361      -0.530036 Decrease 0.83 Neutral 0.85 Neutral 0.065 Neutral -11.89 2 0.8  No  Hbonds                  -0.59 Increase 22.50%           22.49% -  - 2.71 Increase         Unchanged    Unchanged    Unchanged 21  0 13  Based on  FoldX the  mutation slightly reduces the  protein stability  
E162K -0.24                 -0.7 9(Decrease)  0(Large decre4 (disease)                  0.513 Tolerated -0.777 Neutral 0.824 Possibly dam                0.07 0.8  Exposed         Turn                N  - - - - - 0.455                 -0.1              0.358 Stabilizing 0.501 Stabilizing                  -0.045 Destabilizing 5 (Neutral)                  0.204 Neutral 151                0.66 Neutral 0.65 Neutral 0.43 Neutral and n   -0.0953345 Decrease -0.21              83.92 Increase 1.05                89.3 Increase               0.550978       0.319054 Increase 0.83 Neutral 0.79 Neutral 0.337 Neutral -94.16 2 -6  Saturated -0.01 Increase 87.01%                87%                1.19 Low 2.31 Increase         Opposite        Unchanged    Unchanged 27  0 28  Based on  TANGO the  mutation increases the  aggregationtendency of the  protein 
N175S -0.123               -0.35 6(Decrease)  0 (Neutral)     1 (neutral) 1  Tolerated 0.88 Neutral 0  Benign 0.01                0.29 Intermediate Beta Ladder  N  - - - - - 0.067                 -0.4             -1.076 Destabilizing             -0.376 Destabilizing               -0.86 Destabilizing 7 (Neutral)                  0.225 Neutral 133                0.89 Neutral           -  - 0.28 Neutral and n   -0.2025741 Decrease 0.96              24.47 Decrease 2.64              30.74 Increase               0.815999      -0.187528 Decrease 0.83 Neutral 0.77 Neutral 0.116 Neutral 3.42 4 -9  Unsaturated               -0.08 Increase 33.84%           33.84% -  - 2.35 Decrease       Unchanged    Unchanged    Increase 15  1 11  - 
G198R 0.501               -0.54 3(Decrease)  5(Neutral)      7 (disease) 0  Damaging                  -7.733 Deleterious 1  Probably dam                 0.3                     0.07 Buried            Bend               Y  - - - - - 1                    2.41             -1.081 Destabilizing             -1.579 Destabilizing              0.138 Stabilizing      6 (Non-neutr              0.903 Disease 182                0.88 Deleterious 0.63 Deleterious                 -1.53 Destabilizing   0.67816948 Increase 0.73              22.42 Decrease -2.32                7.62 Decrease              0.521893       0.187331 Increase 0.87 Deleterious 0.77 Deleterious                0.878 Disease -257.76 14                   -19.3 No  Hbonds 0.68 Decrease                 60.73%           60.73%                3.29 Median 1.52 Increase         Increase         Increase         Decrease 61  0 98  Based on  FoldX the  mutation reduces the  protein stability 
S227L -0.584                0.13 1 (Increase)   2(Neutral)      4 (disease)                  0.663 Tolerated 0.905 Neutral 0.002 Benign 0.02                0.08 Buried            Coil                 N  - - - - - 0.083               -0.15             -0.082 Destabilizing             -0.097 Destabilizing             -0.349 Destabilizing 6 (Neutral)                  0.202 Neutral 171                0.66 Neutral           -  - 1.86 Stabilizing an  1  Increase 0.2                  10.59 Decrease -1.38                8.53 Decrease              0.612998       0.101624 Increase 0.83 Neutral 0.78 Neutral 0.148 Neutral 11.79 10  2.2  No  Hbonds -0.6 Increase 15.02%           15.02% -  - 2  Increase         Unchanged    Decrease       Increase 45  0 13  - 
D269H -0.137               -0.59 5(Decrease)  1(Large decre6 (disease)                  0.041 Damaging                  -3.573 Deleterious                0.167 Benign            -  - - Helix               -  - - - - - 0.669 3.2                -1.246 Destabilizing              0.305 Stabilizing                  -2.607 Destabilizing 3 (Neutral)                  0.782 Disease 176                0.51 Neutral 0.65 Neutral 2.01 Highly stabili    -0.3899455 Decrease 0.14              17.64 Decrease -1.15              20.12 Decrease              0.779503      -0.110538 Decrease 0.61 Deleterious 0.43 Deleterious                0.621 Disease 11.39 11                     -2.9 No  Hbonds                  -0.57 Increase 17.96%           17.96% 2  Median 2.23 Increase         Opposite        Unchanged    Increase 40  0 48  Based on  FoldX the  mutation reduces the  protein stability 
N252S -0.123               -0.53 7(Decrease)  3(Large decre3 (disease)                  0.387 Tolerated -0.171 Neutral 0  Benign 0.43                0.45 Exposed         Helix               Y  - - - - - 0.423               -0.13             -0.538 Destabilizing               -0.02 Destabilizing             -1.757 Destabilizing 5 (Neutral)                  0.184 Neutral 173                0.83 Neutral           -  - 0.89 Slightly stabil   -0.1876977 Decrease 0.11              46.83 Decrease 1.39                48.5 Increase               0.793589      -0.412245 Decrease 0.83 Neutral 0.74 Neutral 0.161 Neutral 15.36 4                    22.1 Unsaturated               -0.08 Increase 58.61%           58.61% -  - 2.33 Decrease       Unchanged    Unchanged    Increase 15  1 11  - 
R253W -0.878               -0.56 8(Decrease)  0(Large decre6 (disease)                  0.001 Damaging               -0.6057 Deleterious 1  Probably dam              0.03                0.13 Intermediate Helix               Y  - - - - - 0.477 1.7                -0.755 Destabilizing             -1.022 Destabilizing             -0.703 Destabilizing 2 (Non-neutr              0.931 Disease 170                0.88 Deleterious 0.63 Deleterious 2.48 Highly stabili   0.52233862 Increase -0.08              13.38 Increase -0.02              13.54 Decrease              0.634444       0.190483 Increase 0.76 Deleterious 0.56 Deleterious                0.743 Disease -52.44 16  -13  Unsaturated               -1.74 Increase 40.63%           13.48%                2.89 Median 2.17 Unchanged    Decrease       Decrease       Increase 54  1 50  Based on  FoldX the  mutation reduces the  protein stability 
L292F -0.057               -1.16 6(Decrease)  1(Large decre1 (disease) 0.05 Damaging                  -0.778 Neutral 0.367 Benign 0.1                     0.45 Exposed         Helix               Y  - - - - - 0.442                 -0.1             -1.249 Destabilizing             -0.445 Destabilizing             -3.247 Destabilizing 2 (Neutral)                  0.462 Neutral 151                0.83 Neutral 0.65 Neutral -0.72 Slightly desta   -0.1371759 Decrease 0.55              36.77 Decrease 1.33              40.42 Increase                  0.84915        -0.83596 Decrease 0.75 Neutral 0.7  Neutral 0.23 Neutral -17.03 6                  -14.8 No  Hbonds                  -0.32 Increase 38.33%           33.66%                1.49 Low 2.27 Increase         Unchanged    Unchanged    Unchanged 28  1 19  - 
G335S 0.142                 -0.6 4(Increase)    1(Neutral)      6 (disease) 0  Damaging -5.2 Deleterious 1  Probably dam              0.59 0  Buried            Coil                 N  - - - - - 1                 10.96                 -1.3 Destabilizing             -0.306 Destabilizing             -0.591 Destabilizing 6 (Non-neutr              0.908 Disease 171                0.77 Deleterious 0.63 Deleterious                 -4.27 Highly destab  -0.2713381 Decrease 1.59                0.28 Decrease -4.89 0  Decrease              0.618651      -0.539751 Decrease 0.87 Deleterious 0.57 Deleterious                0.858 Disease -0.01 4                     -0.2 No  Hbonds t                    0.19 Decrease 0%  0%                     4.07 High -1.62 Increase         Unchanged    Increase         Unchanged 22  1 92  Based on  FoldX the  mutation severely reduces the  protein stability  
V353E 0.782                 -0.8 2(Decrease)  3(Large decre0 (disease)                  0.001 Damaging                  -4.339 Deleterious 1  Probably dam              0.03                0.02 Buried            Helix               N  - - - - - 0.146                2.65             -2.756 Destabilizing             -1.584 Destabilizing             -0.576 Destabilizing 0 (Non-neutr              0.156 Neutral 132                0.77 Deleterious 0.65 Neutral -2.68 Highly destab  -0.5524886 Decrease 1.79                3.34 Decrease -4.42                1.95 Decrease              0.789789        -1.54786 Decrease 0.76 Deleterious 0.91 Deleterious                0.397 Neutral 5.12 4                     -1.8 No  Hbonds t                    0.63 Decrease 4.86%             4.86%                1.75 Low 1.12 Increase         Increase         Increase         Decrease 43  0 42  Based on  FoldX the  mutation reduces the  protein stability 
S384P -0.352               -0.16 3(Increase)    4 (Neutral)     4 (disease)                  0.145 Tolerated -1.452 Neutral 0.007 Benign 0.01                0.28 Intermediate Coil                 N  - - - - - 0.182                 -0.7             -0.421 Destabilizing               -0.41 Destabilizing             -0.682 Destabilizing 6 (Neutral)     -  - 32                    0.72 Neutral 0.65 Neutral 0.19 Neutral and n  0.23085791 Decrease 1.57              30.05 Decrease -1.63              30.72 Decrease              0.557808            1.4426 Increase 0.84 Neutral 0.63 Neutral 0.373 Neutral 0.68 4                    16.1 No  Hbonds 0.9  Decrease                 28.51%           28.51%                0.55 Neutral 2.32 Increase         Unchanged    Decrease       Decrease 23  2 26  Based on  FoldX the  mutation slightly enhances the  protein stability  
V5A 0.209               -1.78 9(Decrease)  7 (Large decr 7 (neutral) 0.31 Tolerated 0.337 Neutral 0  Benign 0.01                0.22 Intermediate Bend               N  - - - - - 0.246                0.77             -1.189 Destabilizing             -0.549 Destabilizing             -0.442 Destabilizing 8 (Neutral)     - - 42                    0.89 Neutral 0.65 Neutral 0.08 Neutral and n  -1  Decrease 1.62              21.58 Decrease -0.32              20.17 Decrease              0.809748        -2.19831 Decrease 0.83 Neutral 0.72 Neutral 0.067 Neutral -24.17 4                     -8.8 No  Hbonds 0.54 Decrease                 22.19%           22.19% -  - 2.33 Decrease       Unchanged    Unchanged    Unchanged 33  1 23  Based on  FoldX the  mutation slightly reduces the  protein stability and based on  TANGO the  mutation decreases the  aggregation tendency of your protein 
A10V -0.209                0.21 4(Increase)    0(Large decre2 (disease) 0  Damaging                  -3.589 Deleterious 1  Probably dam- - - Beta Ladder  -  - - - - - 0.929                3.44             -0.626 Destabilizing             -1.205 Destabilizing             -3.496 Destabilizing 3 (Non-neutr -  - 155                0.88 Deleterious 0.65 Neutral 1.02 Stabilizing an     -0.2205198 Decrease 0.28 0  Decrease 0.49 0  Increase               0.565601       0.840707 Increase 0.87 Deleterious 0.57 Deleterious                0.692 Disease 0 4 0  No  Hbonds -0.8 Increase 0%  0%                     3.39 Median 1.48 Increase         Unchanged    Unchanged    Unchanged 33  0 80  Based on  FoldX the  mutation reduces the  protein stability 
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